Horizon Therapeutics NASDAQ:HZNP Acuired by Amgen 10/3/23. Horizon is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. The Company pipeline is purposeful: it applyie scientific expertise and courages to bring clinically meaningful therapies to patients. The Company believes science and compassion must work together to transform lives.

Location: | Website: www.horizontherapeutics.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing